Skip to main content
padlock icon - secure page this page is secure

Impact of induction treatment before autologous stem cell transplantation on long‐term outcome in patients with newly diagnosed multiple myeloma

Buy Article:

$59.00 + tax (Refund Policy)

Clinical trials for patients with multiple myeloma (MM) using novel agent (NA)‐based regimens before autologous stem cell transplantation (SCT) have shown improvement in response rates and progression‐free survival (PFS); however they have failed to identify a significant overall survival (OS) benefit. The aim of this study was to analyze the potential impact of initial induction on the feasibility and outcome of subsequent treatment lines in a real clinical practice setting.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: bone marrow transplantation; induction treatment; multiple myeloma

Document Type: Research Article

Publication date: June 1, 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more